Exchange: NYSE·Updated 12:40 PM EDT
News
all
press releases
CL's Q2 Revenues Rise 4.9%: Can Growth Hold Amid Global Volatility?
Colgate's Q2 revenues rise 4.9% as emerging markets, Europe and Hill's drive growth, but U.S. weakness and rising costs cloud the second-half outlook.
Zacks
More News
Why Colgate-Palmolive (CL) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
KMB Cuts 2026 Outlook as China Diaper Disruption Clouds Growth View
KMB cuts its 2026 outlook as China diaper disruption weighs on growth, while productivity and volume-mix gains offer some support.
Zacks
KMB Jumps 15.4% in 3 Months as Transformation Momentum Gains Steam
KMB's 11.7% three-month gain reflects stronger productivity and volume-mix trends, but China and slower growth remain risks.
Zacks
Is KMB Worth Buying as Low Valuation Meets China and Growth Risks?
KMB's valuation discount and productivity gains support the case, but China disruption and slower category growth cloud its outlook.
Zacks
BJ or CL: Which Is the Better Value Stock Right Now?
BJ vs. CL: Which Stock Is the Better Value Option?
Zacks
4 Consumer Staples Stocks to Watch Amid Ongoing Industry Pressures
Despite cost pressures and spending volatility, CL, KMB, CHD and BJ are using strategic initiatives and operational efficiencies to drive growth.
Zacks
Here's Why Colgate-Palmolive (CL) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353
What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353...
Yahoo! Finance: News
Engaging In Options Activity, Noel Wallace Exercises Options Valued At $6.69M In Colgate-Palmolive
In a new SEC filing on August 6, it was revealed that Wallace, Chairman at Colgate-Palmolive (NYSE:CL), executed a significant exercise of company stock options. What Happened: A notable Form 4 filing on Thursday withread more...
Benzinga

Advertisement|Remove ads.